These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 23735537)

  • 1. Ultrafiltration in heart failure with preserved ejection fraction: comparison with systolic heart failure patients.
    Jefferies JL; Bartone C; Menon S; Egnaczyk GF; O'Brien TM; Chung ES
    Circ Heart Fail; 2013 Jul; 6(4):733-9. PubMed ID: 23735537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
    Quiroz R; Doros G; Shaw P; Liang CS; Gauthier DF; Sam F
    Am J Cardiol; 2014 Feb; 113(4):691-6. PubMed ID: 24484862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ultrafiltration, nesiritide, and usual care in acute decompensated heart failure.
    Bartone C; Saghir S; Menon SG; Brosmer J; Kereiakes DJ; Mazur W; Chung ES
    Congest Heart Fail; 2008; 14(6):298-301. PubMed ID: 19076851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
    Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
    J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of estimated plasma volume reduction on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction.
    Takei M; Kohsaka S; Shiraishi Y; Goda A; Izumi Y; Yagawa M; Mizuno A; Sawano M; Inohara T; Kohno T; Fukuda K; Yoshikawa T;
    Circ Heart Fail; 2015 May; 8(3):527-32. PubMed ID: 25737498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafiltration for the treatment of diuretic-resistant, recurrent, acute decompensated heart failure: experience in a single center.
    De Maria E; Pignatti F; Patrizi G; Benenati PM; Ricci S; Cappelli S
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):599-604. PubMed ID: 20442667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.
    Yancy CW; Lopatin M; Stevenson LW; De Marco T; Fonarow GC;
    J Am Coll Cardiol; 2006 Jan; 47(1):76-84. PubMed ID: 16386668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
    Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
    J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cardiopulmonary dysfunction and left atrial remodeling in development of acute decompensated heart failure in chronic heart failure with preserved left ventricular ejection fraction.
    Kaneko H; Koike A; Senoo K; Tanaka S; Suzuki S; Nagayama O; Sagara K; Otsuka T; Matsuno S; Funada R; Uejima T; Oikawa Y; Yajima J; Nagashima K; Kirigaya H; Sawada H; Aizawa T; Yamashita T
    J Cardiol; 2012 May; 59(3):359-65. PubMed ID: 22421198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of volume-overloaded cardiovascular patients treated with ultrafiltration.
    Jaski BE; Romeo A; Ortiz B; Hoagland PM; Stone M; Glaser D; Thomas L; Walsh C; Smith SC
    J Card Fail; 2008 Aug; 14(6):515-20. PubMed ID: 18672200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy.
    Schwartzenberg S; Redfield MM; From AM; Sorajja P; Nishimura RA; Borlaug BA
    J Am Coll Cardiol; 2012 Jan; 59(5):442-51. PubMed ID: 22281246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].
    Macín SM; Perna ER; Címbaro Canella JP; Alvarenga P; Pantich R; Ríos N; Farías EF; Badaracco JR
    Rev Esp Cardiol; 2004 Jan; 57(1):45-52. PubMed ID: 14746717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is cardiac resynchronization therapy an option in heart failure patients with preserved ejection fraction? Justification for the ongoing KaRen project.
    Donal E; Lund L; Linde C; Daubert JC;
    Arch Cardiovasc Dis; 2010; 103(6-7):404-10. PubMed ID: 20800804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
    van Veldhuisen DJ; Linssen GC; Jaarsma T; van Gilst WH; Hoes AW; Tijssen JG; Paulus WJ; Voors AA; Hillege HL
    J Am Coll Cardiol; 2013 Apr; 61(14):1498-506. PubMed ID: 23500300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.
    Maeder MT; Kaye DM
    Int J Cardiol; 2012 Mar; 155(2):249-56. PubMed ID: 21035207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
    J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and outcomes of heart failure with preserved ejection fraction: lessons from epidemiological studies.
    Tsutsui H; Tsuchihashi-Makaya M; Kinugawa S
    J Cardiol; 2010 Jan; 55(1):13-22. PubMed ID: 20122544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction.
    Antonelli L; Katz M; Bacal F; Makdisse MR; Correa AG; Pereira C; Franken M; Fava AN; Serrano Junior CV; Pesaro AE
    Arq Bras Cardiol; 2015 Aug; 105(2):145-50. PubMed ID: 26039659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial.
    Maisel AS; Shah KS; Barnard D; Jaski B; Frivold G; Marais J; Azer M; Miyamoto MI; Lombardo D; Kelsay D; Iqbal N; Taub PR; Kupfer K; Lee E; Clopton P; Zile M; Greenberg B
    J Card Fail; 2016 Apr; 22(4):283-93. PubMed ID: 26433086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.